The scientific literature is practically absent of information regarding proteoglycan and pharmacological resistance in cancer, but Saito and colleagues did demonstrate that GBMs with high contents of GPC1 would be positively correlated to MGMT expression [19]. The gene discussed is MGMT; the disease is cancer.